Carnegie Investment Counsel Boosts Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Carnegie Investment Counsel lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 33.3% during the fourth quarter, Holdings Channel reports. The fund owned 653 shares of the medical equipment provider’s stock after acquiring an additional 163 shares during the period. Carnegie Investment Counsel’s holdings in Intuitive Surgical were worth $341,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the stock. Mirador Capital Partners LP increased its position in shares of Intuitive Surgical by 4.0% during the fourth quarter. Mirador Capital Partners LP now owns 3,666 shares of the medical equipment provider’s stock worth $1,914,000 after acquiring an additional 140 shares during the period. Guardian Financial Partners LLC increased its position in shares of Intuitive Surgical by 1.8% during the fourth quarter. Guardian Financial Partners LLC now owns 1,466 shares of the medical equipment provider’s stock worth $765,000 after acquiring an additional 26 shares during the period. Hennion & Walsh Asset Management Inc. increased its position in shares of Intuitive Surgical by 7.4% during the fourth quarter. Hennion & Walsh Asset Management Inc. now owns 13,237 shares of the medical equipment provider’s stock worth $6,909,000 after acquiring an additional 907 shares during the period. Financial Enhancement Group LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth $884,000. Finally, RMR Wealth Builders increased its holdings in Intuitive Surgical by 4.3% in the fourth quarter. RMR Wealth Builders now owns 5,699 shares of the medical equipment provider’s stock valued at $2,975,000 after buying an additional 236 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $592.64 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $362.14 and a fifty-two week high of $597.68. The company has a market capitalization of $211.09 billion, a price-to-earnings ratio of 95.28, a price-to-earnings-growth ratio of 4.66 and a beta of 1.39. The firm has a 50-day simple moving average of $540.66 and a 200-day simple moving average of $498.77.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Equities research analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Analyst Ratings Changes

Several equities analysts recently commented on ISRG shares. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $522.00 to $650.00 in a report on Monday, December 2nd. The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a report on Friday, October 18th. Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $554.17.

Insider Transactions at Intuitive Surgical

In related news, EVP Brian Edward Miller sold 2,553 shares of the firm’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the completion of the sale, the executive vice president now owns 7,066 shares in the company, valued at $3,638,990. This trade represents a 26.54 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the sale, the chief financial officer now owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. The trade was a 1.22 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 48,190 shares of company stock worth $25,012,927. Company insiders own 0.80% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.